Not all patients with CLL need therapy. In spite of all latest improvements, the iwCLL continue to endorses watchful observation for patients with asymptomatic condition.86 This suggestion is predicated on at least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Partisipasi aktif dari https://ericl318elt6.wikigiogio.com/user